← Open Payments lookup

MARGUERITE ADAMS: Open Payments

NPI 1164139796 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,941 in 166 payments from 27 companies in 2025. Trend: 2023 $3,369 · 2024 $1,548 · 2025 $3,941

Food & beverage: $3,941
CompanyPaymentsAmount
Janssen Biotech, Inc.17$567
ABBVIE INC.32$528
Madrigal Pharmaceuticals9$354
Takeda Pharmaceuticals U.S.A., Inc.12$281
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$265
Regeneron Healthcare Solutions, Inc.15$226
Phathom Pharmaceuticals, Inc.9$205
PFIZER INC.11$200
GENZYME CORPORATION6$173
Ipsen Biopharmaceuticals, Inc5$151

Products named: TREMFYA, DUPIXENT, REZDIFFRA, XIFAXAN, CREON, VOQUEZNA, ENTYVIO, IQIRVO.

Industry payments across MD — which companies pay providers there.